ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.678,05
-0,26%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08319
-0,21%
Bitcoin
70.036,11
-0,14%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. CNBX Pharmaceuticals Inc (QB) (CNBX)

  7. CNBX Pharmaceuticals Inc (QB) (CNBX) News

CNBX

CNBX Pharmaceuticals (QB) (CNBX)

CNBX Pharmaceuticals Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:CNBX
DatumZeitQuelleÜberschriftSymbolFirma
13/02/202422h27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
12/01/202416h13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/07/202316h28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/04/202315h59Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
06/03/202323h04Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
08/02/202313h51Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
13/01/202314h41Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
29/12/202220h52Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
27/12/202213h50Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
25/07/202218h12Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/07/202214h03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
12/04/202215h58Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
16/03/202211h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
18/02/202222h02Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
17/02/202214h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
04/02/202214h26Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
13/01/202219h07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
19/11/202120h52Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
13/09/202115h06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
19/07/202121h48Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/07/202121h51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
06/07/202118h24Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
18/05/202112h07Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
10/05/202116h41Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
28/04/202113h47Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/04/202118h43Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
12/03/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
23/02/202121h28Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
14/01/202122h03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
21/12/202014h55Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CNBXCNBX Pharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:CNBX

Kürzlich von Ihnen besucht

NASDAQ
GOOGL
Alphabet
TG
DTE
Deutsche Telekom
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
RHHBY
Roche (QX)
AMEX
XLE
Energy Select Sector SPDR
TG
CBK
Commerzbank
NYSE
JPM
JP Morgan Chase
FX
EURGBP
Euro vs Sterling
USOTC
BNPQY
BNP Paribas (QX)
TG
MBG
MercedesBenz
FX
EURJPY
Euro vs Yen
TG
NOV
Novo Nordisk
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
AMEX
XLF
Financial Select Sector
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten